Low Testosterone and Mental Health: Depression, Anxiety Risk
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
12 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 12 of 12 clinical reviews.
Testosterone under 300 ng/dL overlaps with depression and anxiety symptoms; men with low T face 2-4x higher depression rates, per Endocrine Society criteria.
A complete guide for caregivers and family members of men with hypogonadism: what the diagnosis means, how treatment works, what to expect at home, and when to seek additional support.
A guide to exercise protocols for male hypogonadism, covering resistance training, aerobic exercise, frequency, intensity, and how structured movement affects testosterone, muscle mass, and metabolic health.
A side-by-side comparison of the major clinical practice guidelines for diagnosing and treating male hypogonadism, including testosterone thresholds, testing protocols, and treatment recommendations from the Endocrine Society, AUA, AACE, ADA, and EAU.
Evidence-based guide to diagnosing and treating male hypogonadism in special populations including obesity, type 2 diabetes, HIV, opioid users, older men, chronic kidney disease, and cancer survivors.
A detailed, guideline-based monitoring schedule for men on testosterone replacement therapy (TRT), covering baseline labs, 3-month check-ins, 6-month evaluations, and annual assessments per Endocrine Society and AUA recommendations.
Evidence-based treatment algorithm for male hypogonadism organized by line of therapy, from lifestyle optimization through testosterone replacement and beyond, based on Endocrine Society, AUA, and EAU guidance.
Male hypogonadism shares strong bidirectional links with obesity, type 2 diabetes, metabolic syndrome, cardiovascular disease, osteoporosis, and depression. Learn how these conditions overlap and what guidelines recommend.
A clinical review of the most promising emerging research, active clinical trials, and next-generation therapies for male hypogonadism, including oral testosterone, selective androgen receptor modulators, and kisspeptin-based treatments.
How genetics and family history influence male hypogonadism risk, which heritable conditions cause low testosterone, and what genetic testing and screening options exist for men and their families.
For obese men with low testosterone, the Endocrine Society recommends lifestyle change first: 5-10% weight loss, resistance training, 7-9 hours of sleep.
Diagnosis requires two morning total testosterone results below 300 ng/dL, confirmed symptoms, then LH and FSH to classify primary vs secondary hypogonadism.